NEW YORK (GenomeWeb) – Affymetrix said today that its board now plans to engage in discussions with Origin Technologies regarding its most recent proposal to acquire Affy for $17.00 per share in an all-cash transaction.

However, Affy's board of directors said it continues to recommend that its stockholders vote in favor of the adoption of a previously approved merger with Thermo Fisher Scientific, in which Thermo Fisher would acquire Affy for $14 per share, or approximately $1.3 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.